(Q42177189)

18 October 2017

Motolimod effectively drives immune activation in advanced cancer patients (English)

1 reference

18 October 2017

Gregory N Dietsch

1

1 reference

18 October 2017

9 February 2016

1 reference

18 October 2017

1 reference

18 October 2017

5

1 reference

18 October 2017

5

1 reference

18 October 2017

e1126037

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

18 October 2017

start time

9 February 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Late-Stage Cancer Patients Remain Highly Responsive to Immune Activation by the Selective TLR8 Agonist Motolimod (VTX-2337).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4910739

Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4910739

Serum levels of vascular endothelial growth factor are increased and correlate with malnutrition, immunosuppression involving MDSCs and systemic inflammation in patients with cancer of the digestive system

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4910739

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4910739

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4910739

Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4910739

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4910739

The effect of immunosuppressive chemotherapy on immune function in patients with malignant disease

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4910739

VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4910739

Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses

29 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27467937

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1080/2162402X.2015.1126037

1 reference

18 October 2017

1 reference

PMC publication ID

4910739

18 October 2017

PubMed publication ID

27467937

1 reference

PMC publication ID

4910739